Sign inJoin waitlistJoin the waitlist

Corinne Summers

Interim Co-Chief Medical Officer · University of Washington School of Medicine

Credentials: · · ·

History

University of Washington School of Medicine
Present

Pediatric Hematology/Oncology
University of Washington School of Medicine
2012–2015
Pediatrics
Children's Hospital of Philadelphia
2009–2012
Florida State University College of Medicine
2005–2009

Research

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Blood · 2017 · 965 citations
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
Blood · 2019 · 238 citations
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage
Transplantation and Cellular Therapy · 2022 · First of 13 authors · 68 citations

Rebecca Gardner
14 papers
Colleen Annesley
12 papers
Ann Dahlberg
10 papers
Marie Bleakley
10 papers
Julie Park
7 papers
Paul Carpenter
7 papers
Adam Lamble
5 papers
Kasey Leger
5 papers
Lauri Burroughs
5 papers
Michael Pulsipher
5 papers
Monica Thakar
5 papers
Alan Wayne
3 papers

Clinical trials

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
Study chair · Active not recruiting · Phase 1, Phase 2
Seattle Children's Hospital
2020–2040
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma
Study chair · Completed · Phase 1
Seattle Children's Hospital
2017–2024
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
Study director · Not yet recruiting · Phase 1
Seattle Children's Hospital
2026–2045
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Study director · Recruiting · Phase 1
Seattle Children's Hospital
2025–2044